ASTS

AST SpaceMobile, Inc.

49
Fundamentals66/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential46/ 100

ASTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

CAT

Caterpillar Inc.

66
Fundamentals74/ 100
Valuation38/ 100
Upside potential83/ 100
Risk potential11/ 100

CAT has the edge over ASTS overall, supported by lower modeled downside and stronger modeled upside.

ASTS Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

CAT Fundamentals

MetricStatus
Healthy
Strong
Strong
Strong

CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.

ASTS PE Valuation

ASTS has no meaningful PE right now: it lost money over the past year.

CAT PE Valuation

CHEAPFAIREXPENSIVE13x26x39x52x
CHEAPFAIREXPENSIVE13x26x39x52x
LevelPEPriceVs current
Cheap15x$380-37%
Fair18x$461-24%
Forward20x$605—
Current24x$605—
Expensive33x$840+39%

Historical ranges are pointers, not guarantees.

CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.

ASTS Forward outlook

MetricOutlook
--
Losses growing
Strong growth
--
Limited
Low

Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.

CAT Forward outlook

MetricOutlook
Improving
Strong growth
Growth
Improving
Moderate
Low

Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.

ASTS Risk to reward

ScenarioChangePrice
Upside+86%$64.16
Downside-46%$18.77

Calculated from the latest close: $34.50 on Nov 12.

ASTS trails CAT on modeled risk to reward, with less potential upside relative to its potential downside.

CAT Risk to reward

ScenarioChangePrice
Upside+52%$918.83
Downside-11%$541.24

Calculated from the latest close: $605.28 on Nov 12.

CAT has a better modeled risk to reward balance than ASTS, with more potential upside relative to its potential downside.

ASTS Earnings Per Share

Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
QuarterTTM EPSYoY
Q3 2026-$2.15-$0.91
Q2 2026-$2.16-$0.27
Q1 2026-$1.80+$0.19
Q4 2025-$1.34+$0.61
Q3 2025-$1.24+$0.88
Q2 2025-$1.89-$0.64
Q1 2025-$1.99-$1.01
Q4 2022-$0.58-$0.21

ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.

CAT Earnings Per Share

Q4 2023: $20.12Q1 2024: $22.13Q2 2024: $21.94Q3 2024: $21.55Q4 2024: $22.05Q1 2025: $20.50Q2 2025: $19.64Q3 2025: $19.46Q4 2025: $18.81Q1 2026: $20.08Q2 2026: $23.23Q3 2026: $25.48Forward: $29.73
Q4 2023: $20.12Q1 2024: $22.13Q2 2024: $21.94Q3 2024: $21.55Q4 2024: $22.05Q1 2025: $20.50Q2 2025: $19.64Q3 2025: $19.46Q4 2025: $18.81Q1 2026: $20.08Q2 2026: $23.23Q3 2026: $25.48Forward: $29.73
QuarterTTM EPSYoY
Forward$29.73+17%
Q3 2026$25.48+31%
Q2 2026$23.23+18%
Q1 2026$20.08-2%
Q4 2025$18.81-15%
Q3 2025$19.46-9.7%
Q2 2025$19.64-10%
Q1 2025$20.50-7.4%
Q4 2024$22.05+9.6%

CAT has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.

ASTS Quarterly Revenue

Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
QuarterRevenueYoY
Q3 2026$42.3M+187%
Q2 2026$31.5M+2627%
Q1 2026$14.7M+1952%
Q4 2025$54.3M+2731%
Q3 2025$14.7M+1240%
Q2 2025$1.2M+28%
Q1 2025$718K+44%
Q3 2022$4.2M+70%

ASTS has the edge over CAT on sales, with more consistent year-over-year improvement.

CAT Quarterly Revenue

Q4 2023: $17.1BQ1 2024: $15.8BQ2 2024: $16.7BQ3 2024: $16.1BQ4 2024: $16.2BQ1 2025: $14.2BQ2 2025: $16.6BQ3 2025: $17.6BQ4 2025: $19.1BQ1 2026: $17.4BQ2 2026: $20.5BQ3 2026: $20.7B
Q4 2023: $17.1BQ1 2024: $15.8BQ2 2024: $16.7BQ3 2024: $16.1BQ4 2024: $16.2BQ1 2025: $14.2BQ2 2025: $16.6BQ3 2025: $17.6BQ4 2025: $19.1BQ1 2026: $17.4BQ2 2026: $20.5BQ3 2026: $20.7B
QuarterRevenueYoY
Q3 2026$20.7B+17%
Q2 2026$20.5B+24%
Q1 2026$17.4B+22%
Q4 2025$19.1B+18%
Q3 2025$17.6B+9.5%
Q2 2025$16.6B-0.7%
Q1 2025$14.2B-9.8%
Q4 2024$16.2B-5%

CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.

ASTS Free Cash Flow

Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
QuarterFree cash flowYoY
Q3 2026-$464.2M-$161.4M
Q2 2026-$694.8M-$341.1M
Q1 2026-$309.7M-$160.7M
Q4 2025-$330.7M-$220.3M
Q3 2025-$302.9M-$239.1M
Q2 2025-$353.6M-$315.3M
Q1 2025-$149M-$61.3M
Q4 2024-$110.5M-$63.2M

ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.

CAT Free Cash Flow

Q4 2023: $3.5BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3.1BQ4 2024: $2.7BQ1 2025: $579MQ2 2025: $2.6BQ3 2025: $3.1BQ4 2025: $2.7BQ1 2026: $1.1BQ2 2026: $3.8BQ3 2026: $3.7B
Q4 2023: $3.5BQ1 2024: $1.6BQ2 2024: $2.7BQ3 2024: $3.1BQ4 2024: $2.7BQ1 2025: $579MQ2 2025: $2.6BQ3 2025: $3.1BQ4 2025: $2.7BQ1 2026: $1.1BQ2 2026: $3.8BQ3 2026: $3.7B
QuarterFree cash flowYoY
Q3 2026$3.7B+19%
Q2 2026$3.8B+47%
Q1 2026$1.1B+97%
Q4 2025$2.7B+0.1%
Q3 2025$3.1B-1.5%
Q2 2025$2.6B-4.2%
Q1 2025$579M-63%
Q4 2024$2.7B-22%

CAT has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.

ASTS Total Shares

Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
PeriodChange %Net change
Quarterly+0.4%+1.1M shares
1 year+10%+27.3M shares
3 years+235%+211M shares
5 years+480%+248M shares
Available history+944%+271M shares

ASTS has 300M diluted shares, up 10% from a year ago.

CAT Total Shares

Q4 2023: 514MQ1 2024: 497MQ2 2024: 490MQ3 2024: 487MQ4 2024: 489MQ1 2025: 477MQ2 2025: 472MQ3 2025: 471MQ4 2025: 472MQ1 2026: 466MQ2 2026: 463MQ3 2026: 461M
Q4 2023: 514MQ1 2024: 497MQ2 2024: 490MQ3 2024: 487MQ4 2024: 489MQ1 2025: 477MQ2 2025: 472MQ3 2025: 471MQ4 2025: 472MQ1 2026: 466MQ2 2026: 463MQ3 2026: 461M
PeriodChange %Net change
Quarterly-0.3%-1.6M shares
1 year-2.1%-9.9M shares
3 years-10%-51.7M shares
5 years-16%-86.7M shares
Available history-19%-107M shares

CAT has the edge over ASTS on shareholder dilution, with a more favorable share count trend.

ASTS Net Leverage

ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CAT Net Leverage

Q4 2023: 1.5xQ1 2024: -0.3xQ2 2024: -0.3xQ3 2024: -0.4xQ4 2024: 1.6xQ1 2025: -0.3xQ2 2025: -0.4xQ3 2025: -0.6xQ4 2025: 2.0xQ1 2026: -0.3xQ2 2026: -0.4xQ3 2026: -0.5x
Q4 2023: 1.5xQ1 2024: -0.3xQ2 2024: -0.3xQ3 2024: -0.4xQ4 2024: 1.6xQ1 2025: -0.3xQ2 2025: -0.4xQ3 2025: -0.6xQ4 2025: 2.0xQ1 2026: -0.3xQ2 2026: -0.4xQ3 2026: -0.5x
QuarterNet LeverageStatus
Q3 2026-0.5xNet Cash
Q2 2026-0.4xNet Cash
Q1 2026-0.3xNet Cash
Q4 20252.0xHealthy
Q3 2025-0.6xNet Cash
Q2 2025-0.4xNet Cash
Q1 2025-0.3xNet Cash
Q4 20241.6xHealthy

CAT has more cash than debt.

ASTS Weekly Momentum

MetricValueStatus
RSI34.1Neutral
Stochastic11.9Oversold

ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).

CAT Weekly Momentum

MetricValueStatus
RSI32.7Neutral
Stochastic6.7Oversold

CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

ASTS PE vs Technology Sector

ASTS has no meaningful PE right now: it lost money over the past year.

CAT PE vs Industrials Sector

MetricCATSector medianRelative
PE24x24x1.1% below
PE %695811 pts above

CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.

ASTS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$44.923% below
20 week MA$57.140% below
50 week MA$75.554% below
100 week MA$57.840% below
200 week MA$33.62.8% above

ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.

CAT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$709.015% below
20 week MA$797.024% below
50 week MA$771.322% below
100 week MA$586.73.2% above
200 week MA$443.137% above

CAT has the edge over ASTS on trend strength, trading above more of its moving averages.

ASTS Yearly ROI

YearStart priceEnd priceROI
2020$9.87$13.4+36%
2021$13.4$8.71-35%
2022$8.71$3.97-54%
2023$3.97$6.03+52%
2024$6.03$22.9+280%
2025$22.9$72.0+214%
2026 YTD$72.0$34.5-52%

ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.

CAT Yearly ROI

YearStart priceEnd priceROI
2020$148.3$179.6+21%
2021$179.6$206.2+15%
2022$206.2$239.9+16%
2023$239.9$295.7+23%
2024$295.7$364.9+23%
2025$364.9$583.0+60%
2026 YTD$583.0$605.3+3.8%

CAT has the edge over ASTS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key